Sort by
Refine Your Search
-
We invite applications from creative and motivated individuals to join Professor Sir Shankar Balasubramanian's group for a 4-year PhD studentship, working on a multidisciplinary project exploiting
-
PhD studentship: Defining the role of the pioneer factor FOXA1 in hormone-dependent cancer Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further
-
Supervisors: Dr Tim Halim and Dr Gregory Hamm Course start: 1st October 2026 Overview The project will be supervised by Dr Tim Halim, Dr Albert Koulman (Institute of Metabolic Science) and Dr Gregory Hamm (AstraZeneca). Project details The tumour immunity cycle involves cyclical trafficking of...
-
equivalent standard from an overseas university, in a relevant subject such as Physics, Chemistry, Materials Science, Chemical Engineering. Full details of the University's entrance requirements and
-
chromatin profiling methods along with CRISPR/Cas9-meduated cell line engineering and various animal models. You will study the effects of the activation or depletion of chromatin-modifying enzymes using
-
@ch.cam.ac.uk , including 'PhD CI ¿ October 2026' in the subject. How to apply Please apply via the University Applicant Portal. For further information about the course and to access the Applicant Portal, click
-
Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further information about the research group, including their most recent publications, please visit their website at https://www.carroll-lab.org.uk/ Prostate cancer is the most common cancer in men in...
-
Supervisor: Professor Florian Markowetz Course start date: 1st Oct 2026 Overview Professor Florian Markowetz wishes to recruit a student to work on the project entitled: “Development and application of computational tools for the early detection and deconstruction of chromosomal instability in...
-
Applications are invited for a fully funded 4-year PhD studentship based in the Department of Biochemistry, University of Cambridge, and the new AstraZeneca Discovery Centre in Cambridge
-
cancer, novel genetically engineered mouse models for the depletion of different CAF populations, in vitro three-dimensional pancreatic tumour organoid/fibroblast co-culture models, CRISPR-based